A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores
- PMID: 10817552
- DOI: 10.1002/1529-0131(200005)43:5<1001::AID-ANR7>3.0.CO;2-P
A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores
Abstract
Objective: To evaluate radiographic progression and the relationship of radiologic scores obtained by the Genant and Larsen methods in a clinical trial of recombinant human interleukin-1 receptor antagonist (IL-1Ra).
Methods: Patients with rheumatoid arthritis (RA) were randomized into 4 groups: placebo (n = 121) or IL-1Ra at a daily dosage of 30 mg (n = 119), 75 mg (n = 116), or 150 mg (n = 116). Hand radiographs obtained at baseline, 24 weeks, and 48 weeks were scored using both methods.
Results: At 24 weeks, by the Genant method, there was significant reduction in the score for progression of joint space narrowing (JSN) and the total score (a combination of erosion and JSN) in all treatment groups. Least-squares mean changes in the Genant erosion score from baseline to 24 weeks were significantly reduced after treatment with IL-1Ra at 30 mg/day and for all IL-1Ra treatment groups combined. The changes corresponded to a reduction of 38% in erosion, 58% in JSN, and 47% in total score. Patients treated with IL-1Ra at 75 mg/day had a significant reduction in the Larsen erosive joint count (LEJC), and all IL-1RA-treated groups combined showed a 45% reduction. Correlations (r) between the Genant total and Larsen scores were 0.84 at baseline, 0.83 at week 24, and 0.83 at week 48 (P < 0.0001); correlations between the Genant erosion score and the LEJC were 0.83 (P < 0.0001) at all visits; correlations between the Genant total and the Larsen scores were 0.32 and 0.49 (P < 0.0001) for progression from baseline to week 24 and from baseline to week 48, respectively; correlations between the Genant erosion score and the LEJC were 0.36 and 0.41 (P < 0.0001) for progression to weeks 24 and 48, respectively.
Conclusion: IL-1Ra reduced radiologic progression of RA. Scores by the 2 methods correlated strongly for each individual time point, but much less strongly for assessments of disease progression.
Similar articles
-
Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.Clin Ther. 2004 Dec;26(12):1960-75. doi: 10.1016/j.clinthera.2004.12.019. Clin Ther. 2004. PMID: 15823761 Review.
-
Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial.Arthritis Rheum. 2003 Apr;48(4):927-34. doi: 10.1002/art.10870. Arthritis Rheum. 2003. PMID: 12687534 Clinical Trial.
-
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.Arthritis Rheum. 2002 Mar;46(3):614-24. doi: 10.1002/art.10141. Arthritis Rheum. 2002. PMID: 11920396 Clinical Trial.
-
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.Arthritis Rheum. 1998 Dec;41(12):2196-204. doi: 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2. Arthritis Rheum. 1998. PMID: 9870876 Clinical Trial.
-
[Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].Przegl Lek. 2002;59(11):916-8. Przegl Lek. 2002. PMID: 12715722 Review. Polish.
Cited by
-
Emerging strategies for nanomedicine in autoimmunity.Adv Drug Deliv Rev. 2024 Apr;207:115194. doi: 10.1016/j.addr.2024.115194. Epub 2024 Feb 10. Adv Drug Deliv Rev. 2024. PMID: 38342243 Review.
-
Bone Involvement in Rheumatoid Arthritis and Spondyloartritis: An Updated Review.Biology (Basel). 2023 Oct 9;12(10):1320. doi: 10.3390/biology12101320. Biology (Basel). 2023. PMID: 37887030 Free PMC article. Review.
-
Gasdermin D deficiency attenuates arthritis induced by traumatic injury but not autoantibody-assembled immune complexes.Arthritis Res Ther. 2021 Nov 16;23(1):286. doi: 10.1186/s13075-021-02668-8. Arthritis Res Ther. 2021. PMID: 34784954 Free PMC article.
-
Chronic colitis upregulates microRNAs suppressing brain-derived neurotrophic factor in the adult heart.PLoS One. 2021 Sep 20;16(9):e0257280. doi: 10.1371/journal.pone.0257280. eCollection 2021. PLoS One. 2021. PMID: 34543287 Free PMC article.
-
IL-1β-driven osteoclastogenic Tregs accelerate bone erosion in arthritis.J Clin Invest. 2021 Sep 15;131(18):e141008. doi: 10.1172/JCI141008. J Clin Invest. 2021. PMID: 34343136 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical